Research

Experts, patients warn Congress about the burden of long COVID

Wed, 2024-01-24 18:24 — mike kraft

‘On par with cancer and heart disease’: Experts, patients warn Congress about the burden of long COVID as the government blows through $1.15 billion without finding a cure There’s a strong argument to be made for the government to provide the funding–and then mostly get out of the way. Yahoo Finance

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Experts, patients warn Congress about the burden of long COVID
Log in or register to post comments

N.1 variant accounts for about 86% of COVID cases in US --CDC

Wed, 2024-01-24 13:30 — mike kraft

CDC says JN.1 variant accounts for about 86% of COVID cases in US The U.S. Centers for Disease Control and Prevention (CDC) on Monday estimated COVID subvariant JN.1 to account for about 85.7% of cases in the United States, as of Jan. 19. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about N.1 variant accounts for about 86% of COVID cases in US --CDC
Log in or register to post comments

Emergency listing for Corbevax COVID vaccine approved by WHO

Tue, 2024-01-23 19:52 — mike kraft

WHO grants emergency listing for Corbevax COVID vaccine Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines. CIDRAP

The World Health Organization (WHO) has approved another COVID-19 vaccine for emergency use listing (EUL): Corbevax, a recombinant protein–based vaccine developed by scientists at Texas Children's Hospital and Baylor College of Medicine.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about Emergency listing for Corbevax COVID vaccine approved by WHO
Log in or register to post comments

Analysis: How long immunity might last after a COVID infection

Tue, 2024-01-23 19:40 — mike kraft

How long does immunity last after a COVID infection? While some lucky people believe they’ve never had COVID, many are facing their second, third or even fourth infection. Here’s what the evidence shows. The Conversation

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Analysis: How long immunity might last after a COVID infection
Log in or register to post comments

COVID, flu and other viruses can lead to increases risk of heart problems --doctors

Tue, 2024-01-23 19:31 — mike kraft

Why Americans may be at risk of heart problems as COVID, flu spread: Expert As COVID, flu and other viruses continue spreading, an expert says respiratory illness season can lead to an increased risk of heart problems for many Americans. ABC News ABC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID, flu and other viruses can lead to increases risk of heart problems --doctors
Log in or register to post comments

Study indicates how COVID-19 Vaccines and Infections Are Tweaking Our Immunity

Tue, 2024-01-23 09:06 — mike kraft

How COVID-19 Vaccines and Infections Are Tweaking Our Immunity A study shows our immune systems may be getting better at protecting against new variants. TIME

Your immune system may be getting smarter every time you encounter COVID-19, a new study suggests. After getting vaccinated and infected, the immune system generates broader defenses against the virus, including against new variants.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Study indicates how COVID-19 Vaccines and Infections Are Tweaking Our Immunity
Log in or register to post comments

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study

Mon, 2024-01-22 11:27 — mike kraft

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 The length of COVID-19 symptoms was on average 36 hours shorter in the simnotrelvir group. CIDRAP

..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study
Log in or register to post comments

Long Covid: Change in a handful of blood proteins may pave way to tests and treatment --study

Fri, 2024-01-19 10:32 — mike kraft

https://www.nbcnews.com/health/health-news/long-covid-cause-study-immune-system-complement-response-rcna134530

Scientists have identified a persistent change in a handful of blood proteins in people with long Covid that indicates that an important part of their immune system remains on high alert for months after an acute infection.

The findings, published Thursday in the journal Science, could help explain what causes the persistent fatigue, brain fog and other debilitating symptoms of long Covid, as well as pave the way for diagnostic tests and potentially, a long-awaited treatment, experts say.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: